International Patent: BISPECIFIC ANTI-EGFR/C-MET ANTIBODY-DRUG CONJUGATES

GENEVA, July 18 -- JANSSEN BIOTECH, INC. filed a patent application (IB2026/050234) for “BISPECIFIC ANTI-EGFR/C-MET ANTIBODY-DRUG CONJUGATES”. With publication no. WO/2026/150367, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 47/68

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....